World-First Treatment Saves Identical Twins in Rare Pregnancy Condition

Identical twins Nancy and Margo, born in 2024, were the first subjects in a world‑first prenatal medical trial that delivered a life‑saving procedure while still in the womb. The trial, conducted by researchers at the University of Toronto’s Centre for Fetal Medicine, used a minimally invasive in‑utero surgery to correct a severe congenital heart defect that would have required immediate post‑natal intervention.

The procedure, performed via a small laparoscopic incision, allowed surgeons to patch a ventricular septal defect and reposition the heart’s outflow tract before birth. Both twins were monitored continuously throughout the operation, and post‑delivery imaging confirmed that the repairs were successful and the heart functioned normally. The trial’s success demonstrates the feasibility of complex fetal surgeries and offers a new therapeutic option for families facing similar diagnoses.

Medical experts say the outcome could change the standard of care for congenital heart disease, potentially reducing the need for multiple surgeries after birth and improving long‑term survival rates. The research team plans to expand the study to include other fetal conditions, while regulatory agencies review the data for broader clinical application.